Form 8-K - Current report:
SEC Accession No. 0001799191-23-000027
Filing Date
2023-06-20
Accepted
2023-06-16 18:15:08
Documents
13
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K toi-20230615.htm   iXBRL 8-K 55702
  Complete submission text file 0001799191-23-000027.txt   239835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20230615.xsd EX-101.SCH 2318
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20230615_def.xml EX-101.DEF 16055
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20230615_lab.xml EX-101.LAB 30837
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20230615_pre.xml EX-101.PRE 16738
7 EXTRACTED XBRL INSTANCE DOCUMENT toi-20230615_htm.xml XML 14893
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 231022665
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine